Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


22.05.2017

3 Am J Dermatopathol
1 Am J Ophthalmol
1 Am J Pathol
2 BMC Cancer
25 Br J Dermatol
4 Cancer
1 Cancer Res
1 Clin Dermatol
3 Clin Exp Dermatol
16 Eur J Dermatol
17 Int J Cancer
1 Int J Clin Pract
1 Int J Dermatol
1 Intern Med
2 J Cutan Pathol
6 J Invest Dermatol
1 Lancet Infect Dis
1 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. BERDUGO J, Dumont-Mackay V, Brissy-Lachery S, Leclerc YE, et al
    Cutaneous Apocrine Carcinoma With an In Situ Component and Histiocytoid and Signet-Ring Cells.
    Am J Dermatopathol. 2017;39:e76-e78.
    PubMed     Text format     Abstract available

  2. VALERO-TORRES A, Prieto VG, Nagarajan P, Torres-Cabala CA, et al
    Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall.
    Am J Dermatopathol. 2017;39:468-470.
    PubMed     Text format     Abstract available

  3. ELBENDARY A, Xue R, Valdebran M, Torres KMT, et al
    Diagnostic Criteria in Intraepithelial Pagetoid Neoplasms: A Histopathologic Study and Evaluation of Select Features in Paget Disease, Bowen Disease, and Melanoma In Situ.
    Am J Dermatopathol. 2017;39:419-427.
    PubMed     Text format     Abstract available


    Am J Ophthalmol

  4. SAEED HN, Kohanim S, Le HG, Chodosh J, et al
    Stevens-Johnson syndrome and corneal ectasia: management and a case for association.
    Am J Ophthalmol. 2016 Jul 4. pii: S0002-9394(16)30313.
    PubMed     Text format     Abstract available


    Am J Pathol

  5. KARAKAS C, Biernacka A, Bui T, Sahin A, et al
    Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.
    Am J Pathol. 2016 May 13. pii: S0002-9440(16)30080.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. SEKULIC A, Migden MR, Basset-Seguin N, Garbe C, et al
    Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
    BMC Cancer. 2017;17:332.
    PubMed     Text format     Abstract available

  7. GAMBICHLER T, Strutzmann S, Tannapfel A, Susok L, et al
    Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.
    BMC Cancer. 2017;17:327.
    PubMed     Text format     Abstract available


    Br J Dermatol

  8. APFELBACHER CJ, Ofenloch RF
    The impact of skin conditions on generic health-related quality of life.
    Br J Dermatol. 2017;176:1109-1110.
    PubMed     Text format    

  9. JIMENEZ F
    Incorporating hair follicle cells in artificial skin.
    Br J Dermatol. 2017;176:1124-1125.
    PubMed     Text format    

  10. ZHUANG K, Tang J, Ran Y
    Image Gallery: Acute primary cutaneous nocardiosis due to Nocardia brasiliensis.
    Br J Dermatol. 2017;176:e97.
    PubMed     Text format    

  11. KAUR P
    Hair-follicle dermal papilla and sheath fibroblasts provide a supportive microenvironment for human skin regeneration.
    Br J Dermatol. 2017;176:1123-1124.
    PubMed     Text format    

  12. RYAN C
    Identification of pharmacogenetic markers of treatment response to biologic therapies in psoriasis - is there a benefit?
    Br J Dermatol. 2017;176:1127-1128.
    PubMed     Text format    

  13. SWETTER SM
    Challenges of treating melanoma in situ, lentigo maligna type: is pathological clearance the gold standard?
    Br J Dermatol. 2017;176:1115-1116.
    PubMed     Text format    

  14. ELLIS RA
    T-type calcium channels as potential biomarkers in melanoma.
    Br J Dermatol. 2017;176:1122.
    PubMed     Text format    

  15. WANG L, Long H, Wen H, Liu Z, et al
    Image Gallery: Generalized mucosal and cutaneous papillomatosis, a unique sign of malignant acanthosis nigricans.
    Br J Dermatol. 2017;176:e99.
    PubMed     Text format    

  16. KRENGEL S, Reyes-Mugica M
    Melanoma risk in congenital melanocytic naevi.
    Br J Dermatol. 2017;176:1114.
    PubMed     Text format    

  17. RAMOT Y
    Psoriasis and osteoporosis: the debate continues.
    Br J Dermatol. 2017;176:1117-1118.
    PubMed     Text format    

  18. FARRAR MD
    Topical photodynamic therapy: the preferred choice for cutaneous field-cancerization?
    Br J Dermatol. 2017;176:1116-1117.
    PubMed     Text format    

  19. MAGIN P
    Aggression and its associations in patients with skin disease.
    Br J Dermatol. 2017;176:1118-1119.
    PubMed     Text format    

  20. GRIEWANK KG
    Epidermal growth factor receptor gaining impact in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2017;176:1126-1127.
    PubMed     Text format    

  21. YANG CW, Tsai TF
    Image Gallery: Resolution of lichen striatus in a patient with coexisting chronic plaque psoriasis and vitiligo during secukinumab treatment.
    Br J Dermatol. 2017;176:e96.
    PubMed     Text format    

  22. PUIG L, Putrik P
    Psoriasis: inequality or individualized care?
    Br J Dermatol. 2017;176:1111-1113.
    PubMed     Text format    

  23. DRUCKER AM
    Taking steps to improve the assessment and management of rosacea.
    Br J Dermatol. 2017;176:283-284.
    PubMed     Text format    

  24. WEISSHAAR E
    Outcome measures in patients with chronic pruritus: moving forward but still a long way to go.
    Br J Dermatol. 2017;176:291-292.
    PubMed     Text format    

  25. FOLSTER-HOLST R
    Severe systemic juvenile xanthogranuloma is an indication for systemic therapy.
    Br J Dermatol. 2017;176:302-304.
    PubMed     Text format    

  26. FLETCHER J, Haniffa M
    Mechanisms of immune evasion in extramammary Paget disease.
    Br J Dermatol. 2017;176:293-294.
    PubMed     Text format    

  27. HASHIMOTO T
    Induced autoimmune bullous diseases.
    Br J Dermatol. 2017;176:304-305.
    PubMed     Text format    

  28. EGEBERG A
    Evidence-based management of rosacea.
    Br J Dermatol. 2017;176:300-301.
    PubMed     Text format    

  29. INGRAM JR, Burton T
    NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
    Br J Dermatol. 2017;176:281-282.
    PubMed     Text format    

  30. SAKAI A, Shimomura Y, Ansai O, Saito Y, et al
    Linagliptin-associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180.
    Br J Dermatol. 2017;176:541-543.
    PubMed     Text format    

  31. SMITH CH, Jabbar-Lopez ZK, Yiu ZZ, Bale T, et al
    British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017.
    Br J Dermatol. 2017 May 17. doi: 10.1111/bjd.15665.
    PubMed     Text format     Abstract available

  32. RODRIGUEZ-JIMENEZ P, Chicharro P, Godoy A, Llamas-Velasco M, et al
    No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab.
    Br J Dermatol. 2017 May 16. doi: 10.1111/bjd.15654.
    PubMed     Text format     Abstract available


    Cancer

  33. BRADLEY MC, Black A, Freedman AN, Barron TI, et al
    Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Cancer. 2016 May 3. doi: 10.1002/cncr.30004.
    PubMed     Text format     Abstract available

  34. GUO X, Cai Q, Bao P, Wu J, et al
    Long-term soy consumption and tumor tissue MicroRNA and gene expression in triple-negative breast cancer.
    Cancer. 2016 May 16. doi: 10.1002/cncr.29981.
    PubMed     Text format     Abstract available

  35. GIESE-DAVIS J, Bliss-Isberg C, Wittenberg L, White J, et al
    Peer-counseling for women newly diagnosed with breast cancer: A randomized community/research collaboration trial.
    Cancer. 2016 May 19. doi: 10.1002/cncr.30036.
    PubMed     Text format     Abstract available

  36. OWUSU C, Margevicius S, Schluchter M, Koroukian SM, et al
    Vulnerable elders survey and socioeconomic status predict functional decline and death among older women with newly diagnosed nonmetastatic breast cancer.
    Cancer. 2016 Jun 27. doi: 10.1002/cncr.30046.
    PubMed     Text format     Abstract available


    Cancer Res


  37. Correction: Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.
    Cancer Res. 2017;77:2770.
    PubMed     Text format    


    Clin Dermatol

  38. MISERY L
    Neuropsychiatric factors in sensitive skin.
    Clin Dermatol. 2017;35:281-284.
    PubMed     Text format     Abstract available


    Clin Exp Dermatol

  39. STORAN ER, O' Gorman SM, Hawkins P, Aalto L, et al
    Alpha-1-antitrypsin deficiency-related panniculitis: two cases with diverse clinical courses.
    Clin Exp Dermatol. 2017 May 17. doi: 10.1111/ced.13102.
    PubMed     Text format     Abstract available

  40. WEST J, Ogston S, Berg J, Palmer C, et al
    HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment.
    Clin Exp Dermatol. 2017 May 17. doi: 10.1111/ced.13100.
    PubMed     Text format     Abstract available

  41. BROWN A, Watchorn RE, Cope NJ, Downs AMR, et al
    Proteinase 3-antineutrophil cytoplasmic antibody-associated cutaneous vasculitis without systemic involvement.
    Clin Exp Dermatol. 2017 May 17. doi: 10.1111/ced.13110.
    PubMed     Text format    


    Eur J Dermatol

  42. DIKA E, Ravaioli GM, Fanti PA, Piraccini BM, et al
    Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3023.
    PubMed     Text format     Abstract available

  43. DIKA E, Fanti PA, Vaccari S, Capizzi E, et al
    Oestrogen and progesterone receptor in melanoma and nevi: an immunohistochemical study.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3019.
    PubMed     Text format     Abstract available

  44. TOTSUKA A, Omori-Miyake M, Kawashima M, Yagi J, et al
    Expression of keratin 1, keratin 10, desmoglein 1 and desmocollin 1 in the epidermis: possible downregulation by interleukin-4 and interleukin-13 in atopic dermatitis.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.2985.
    PubMed     Text format     Abstract available

  45. BLAIZOT R, Goiset A, Caumes E, Gabriel F, et al
    Cutaneous larva migrans: a case in Bordeaux, France and a systematic review of locally acquired cases in Europe.
    Eur J Dermatol. 2017 May 16. doi: 10.1684/ejd.2017.3043.
    PubMed     Text format    

  46. YOKOTA K, Kono M, Mori S, Shimizu K, et al
    A solid variant of primary cutaneous cribriform carcinoma: a small, stable, long-term lesion.
    Eur J Dermatol. 2017 May 16. doi: 10.1684/ejd.2017.3034.
    PubMed     Text format    

  47. MATSUZAKI Y, Kaneko T, Makita E, Rokunohe A, et al
    Postoperative maxillary cyst presenting as a skin tumour on the cheek.
    Eur J Dermatol. 2017 May 16. doi: 10.1684/ejd.2017.3046.
    PubMed     Text format    

  48. NAMIKI T, Nojima K, Hanafusa T, Mori H, et al
    A case of basal cell carcinoma with a neighbouring melanocytic nevus: dermoscopic features.
    Eur J Dermatol. 2017 May 16. doi: 10.1684/ejd.2017.3051.
    PubMed     Text format    

  49. BASSINO S, Ribero S, Miniotti M, Picardi A, et al
    Emotional distress and health-related quality of life among cutaneous melanoma follow-up outpatients: the role of self-perception of body image and surgical scarring.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3048.
    PubMed     Text format    

  50. CORDISCO S, Magenta A, Briganti S, Teson M, et al
    Accelerated features of senescence in cultured type 2 diabetic skin fibroblasts.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3020.
    PubMed     Text format    

  51. PARADISI A, Didona B, Tabolli S, Ricci F, et al
    Reduced frequency of non-melanoma skin cancer in 72,739 patients with psoriasis: a retrospective study.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3032.
    PubMed     Text format     Abstract available

  52. RUKSHA TG, Komina AV, Palkina NV
    MicroRNA in skin diseases.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3024.
    PubMed     Text format     Abstract available

  53. PINELLI S, Basile S, Benedetti Panici P, D'Erme AM, et al
    Association between HCV infection and cutaneous-mucosal lichen planus: an update.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3009.
    PubMed     Text format    

  54. RAFFIN D, Zaragoza J, Georgescou G, Mourtada Y, et al
    High-frequency ultrasound imaging of cutaneous neurofibroma in patients with neurofibromatosis type I.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3015.
    PubMed     Text format     Abstract available

  55. MASSON REGNAULT M, Hegazy S, Konstantinou MP, Uthurriague C, et al
    Efficacy of hospital inpatient topical treatment for severe adult atopic dermatitis: a retrospective study of 56 patients.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3033.
    PubMed     Text format    

  56. LHEURE C, Ingen-Housz-Oro S, Guignard S, Inaoui R, et al
    Dermatitis herpetiformis and bone mineral density: analysis of a French cohort of 53 patients.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3029.
    PubMed     Text format     Abstract available

  57. FATIGATO G, Capitani S, Milani D, Grassilli S, et al
    Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3026.
    PubMed     Text format     Abstract available


    Int J Cancer

  58. FRY EA, Taneja P, Inoue K
    Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
    Int J Cancer. 2016 Aug 23. doi: 10.1002/ijc.30399.
    PubMed     Text format     Abstract available

  59. KIISKI JI, Fagerholm R, Tervasmaki A, Pelttari LM, et al
    FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.
    Int J Cancer. 2016 Aug 20. doi: 10.1002/ijc.30394.
    PubMed     Text format     Abstract available

  60. LI J, Humphreys K, Eriksson M, Dar H, et al
    Worse quality of life in young and recently-diagnosed breast cancer survivors compared to female survivors of other cancers: A cross-sectional study.
    Int J Cancer. 2016 Aug 3. doi: 10.1002/ijc.30370.
    PubMed     Text format     Abstract available

  61. AYRAULT-PIAULT S, Grosclaude P, Daubisse-Marliac L, Pascal J, et al
    Are disparities of waiting times for breast cancer care related to socio-economic factors? A regional population-based study (France).
    Int J Cancer. 2016 Jul 12. doi: 10.1002/ijc.30266.
    PubMed     Text format     Abstract available

  62. TOMCZAK A, Miller AB, Weichenthal SA, To T, et al
    Long-term exposure to fine particulate matter air pollution and the risk of lung cancer among participants of the Canadian National Breast Screening Study.
    Int J Cancer. 2016 Jul 6. doi: 10.1002/ijc.30255.
    PubMed     Text format     Abstract available

  63. MANTHRAVADI S, Shrestha A, Madhusudhana S
    Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis.
    Int J Cancer. 2016 May 13. doi: 10.1002/ijc.30185.
    PubMed     Text format     Abstract available

  64. LIU S, Wang Y, Xue W, Liu H, et al
    Genetic Variants in the Genes Encoding Rho GTPases and Related Regulators Predict Cutaneous Melanoma-specific Survival.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30785.
    PubMed     Text format     Abstract available

  65. LIN Y, Chahal HS, Wu W, Cho HG, et al
    Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30786.
    PubMed     Text format     Abstract available

  66. NOMURA SJ, Dash C, Rosenberg L, Yu J, et al
    Adherence to diet, physical activity and body weight recommendations and breast cancer incidence in the Black Women's Health Study.
    Int J Cancer. 2016 Aug 31. doi: 10.1002/ijc.30410.
    PubMed     Text format     Abstract available

  67. HE W, Lindstrom LS, Hall P, Czene K, et al
    Cause-specific mortality in women with breast cancer in situ.
    Int J Cancer. 2016 Sep 4. doi: 10.1002/ijc.30413.
    PubMed     Text format     Abstract available

  68. SILVERSMIT G, Jegou D, Vaes E, Van Hoof E, et al
    Cure of cancer for seven cancer sites in the Flemish Region.
    Int J Cancer. 2017;140:1102-1110.
    PubMed     Text format     Abstract available

  69. WAKEHAM K, Kavanagh K, Cuschieri K, Millan D, et al
    HPV status and favorable outcome in vulvar squamous cancer.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30523.
    PubMed     Text format     Abstract available

  70. KARASNEH RA, Murray LJ, Cardwell CR
    Cardiac glycosides and breast cancer risk: A systematic review and meta-analysis of observational studies.
    Int J Cancer. 2016 Nov 15. doi: 10.1002/ijc.30520.
    PubMed     Text format     Abstract available

  71. KRAUS C, Hoyer J, Vasileiou G, Wunderle M, et al
    Gene panel sequencing in familial Breast/Ovarian Cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30428.
    PubMed     Text format     Abstract available

  72. STRAND F, Humphreys K, Eriksson M, Li J, et al
    Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30427.
    PubMed     Text format     Abstract available

  73. SYNNOTT NC, Murray A, McGowan PM, Kiely M, et al
    Mutant p53: A Novel Target for the Treatment of Patients with Triple-Negative Breast Cancer?
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30425.
    PubMed     Text format     Abstract available

  74. ROMIEU I, Ferrari P, Chajes V, de Batlle J, et al
    Fiber intake modulates the association of alcohol intake with breast cancer.
    Int J Cancer. 2016 Sep 6. doi: 10.1002/ijc.30415.
    PubMed     Text format     Abstract available


    Int J Clin Pract

  75. HARRIES M, Mohr P, Grange F, Ehness R, et al
    Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS).
    Int J Clin Pract. 2017;71.
    PubMed     Text format     Abstract available


    Int J Dermatol

  76. VELASCO-TAMARIZ V, Burillo-Martinez S, Prieto-Barrios M, Calleja-Algarra A, et al
    Widespread biphasic amyloidosis related to ipilimumab treatment for metastatic melanoma.
    Int J Dermatol. 2017 May 12. doi: 10.1111/ijd.13642.
    PubMed     Text format    


    Intern Med

  77. KISHIDA D, Sato M, Kobayashi C, Ueno KI, et al
    Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus.
    Intern Med. 2017;56:1253-1257.
    PubMed     Text format     Abstract available


    J Cutan Pathol

  78. HO T, Oliver-Krasinski J, Russo P, Taylor J, et al
    Including Langerhans cell histiocytosis in the differential diagnosis of skin tumors with osteoclast-like multinucleated giant cells.
    J Cutan Pathol. 2017 May 16. doi: 10.1111/cup.12954.
    PubMed     Text format    

  79. GULSEREN D, Kwock JM, Patterson JW
    A case of combined desmoplastic trichoepithelioma and compound melanocytic nevus.
    J Cutan Pathol. 2017 May 16. doi: 10.1111/cup.12948.
    PubMed     Text format    


    J Invest Dermatol

  80. LEWANDOWSKI KT, Thiede R, Guido N, Daniel WL, et al
    Topically-delivered tumor necrosis factor-targeted gene regulation for psoriasis.
    J Invest Dermatol. 2017 May 11. pii: S0022-202X(17)31493.
    PubMed     Text format    

  81. BUSTOS MA, Ono S, Marzese DM, Oyama T, et al
    MiR-200a Regulates CDK4/6 Inhibitor Effect by targeting CDK6 in Metastatic Melanoma.
    J Invest Dermatol. 2017 May 16. pii: S0022-202X(17)31528.
    PubMed     Text format     Abstract available

  82. LIM JY, Ryu DB, Lee SE, Park G, et al
    Mesenchymal stem cells (MSCs) attenuate cutaneous sclerodermatous graft-versus-host disease (Scl-GVHD) through inhibition of immune cell infiltration in a mouse model.
    J Invest Dermatol. 2017 May 16. pii: S0022-202X(17)31535.
    PubMed     Text format     Abstract available

  83. SHI Q, Liu H, Han P, Li C, et al
    Genetic Variants in WNT2B and BTRC Predict Melanoma Survival.
    J Invest Dermatol. 2017 May 9. pii: S0022-202X(17)31489.
    PubMed     Text format     Abstract available

  84. LAW MH, Medland SE, Zhu G, Yazar S, et al
    Genome-Wide Association Reveals Pigmentation Genes Play a Role in Skin Aging.
    J Invest Dermatol. 2017 May 11. pii: S0022-202X(17)31492.
    PubMed     Text format     Abstract available

  85. VAN DE NES JAP, Koelsche C, Gessi M, Moller I, et al
    Activating CYSLTR2 and PLCB4 mutations in primary leptomeningeal melanocytic tumors.
    J Invest Dermatol. 2017 May 9. pii: S0022-202X(17)31488.
    PubMed     Text format    


    Lancet Infect Dis

  86. VERWEIJ PE, Zhang J, Debets AJ, Meis JF, et al
    In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management.
    Lancet Infect Dis. 2016 Sep 13. pii: S1473-3099(16)30138.
    PubMed     Text format     Abstract available


    N Engl J Med

  87. MANSOUR MK, Letourneau AR, Wallace ZS, Fintelmann FJ, et al
    Case 15-2017 - A 27-Year-Old Woman with Anemia, Thrombocytosis, and Skin Lesions after Travel Abroad.
    N Engl J Med. 2017;376:1973-1981.
    PubMed     Text format    


    PLoS One

  88. KANHAYUWA L, Coutts RH
    Short Interspersed Nuclear Element (SINE) Sequences in the Genome of the Human Pathogenic Fungus Aspergillus fumigatus Af293.
    PLoS One. 2016;11:e0163215.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: